| Stage | DHR | % of rev | CGNX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $313M | 100.00% | DHR ×20.91 |
| Gross profit | $3.8B | 58.54% | $222M | 70.76% | CGNX +12.2pp |
| Operating income | $1.2B | 19.00% | $101M | 32.17% | CGNX +13.2pp |
| Pre-tax income | $1.1B | 17.27% | $103M | 32.96% | CGNX +15.7pp |
| Net income | $1.2B | 18.84% | $85M | 27.07% | CGNX +8.2pp |
| Stage | DHR | CGNX | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $313M100.00% | DHR ×20.91 |
| Gross profit | 58.54%$3.8B | 70.76%$222M | CGNX +12.2pp |
| Operating income | 19.00%$1.2B | 32.17%$101M | CGNX +13.2pp |
| Pre-tax income | 17.27%$1.1B | 32.96%$103M | CGNX +15.7pp |
| Net income |
| 18.84%$1.2B |
| 27.07%$85M |
| CGNX +8.2pp |
None
No disclosed counterparties: DHR.